NHS Trusts Reject Palantir Patient Data Platform Over Performance Concerns
Multiple health bodies find Palantir's federated data platform redundant compared to existing local systems.
1Widespread Rejection of Platform
Numerous NHS trusts across England are actively rejecting Palantir’s £330m federated data platform. Freedom of information responses reveal that health leaders believe existing local systems offer equal or superior functionality. From Gateshead to Truro, organizations report that the platform fails to provide significant improvements over current infrastructure, leading many to decline implementation.
2Operational Redundancy Concerns
Health boards, including Greater Manchester, have explicitly labeled the Palantir system as duplicative and retrograde. Trusts like the University Hospitals of North Midlands stated the platform lacks functionality beyond what they already possess. Consequently, these institutions are opting to maintain their current software rather than transitioning to the controversial US-based technology.
3Political and Ethical Scrutiny
The government faces a critical decision regarding a break clause in the seven-year NHS-Palantir contract. Public opposition is fueled by Palantir’s previous work with the Israeli military and US homeland security. Furthermore, co-founder Peter Thiel’s past critical remarks about the NHS have intensified public distrust and fueled protests outside the company's London headquarters.
4Evidence of Limited Benefit
Data gathered by the health campaign group Medact shows at least 16 trusts have confirmed they do not use the platform. Institutions like Dorset HealthCare and Humber Teaching NHS Foundation Trust have no plans to adopt it. These findings suggest that the centralized mandate for the platform is facing significant resistance from local practitioners.
5Palantir’s Defense and Metrics
Palantir maintains the program is successful, citing a green delivery rating and claims of exceeding benefit forecasts. The company reports that trusts using the platform have performed 117,000 additional operations. However, NHS England notes these statistics cannot definitively prove cause and effect, as other variables remain uncontrolled within the complex healthcare environment.
6Calls for Local Innovation
Critics and parliamentary committees are urging the government to terminate the contract, favoring interoperability over centralized solutions. Martin Wrigley of the science and technology committee argued that Palantir over-promises and under-delivers. Experts suggest that backing internal NHS innovation and skilled data professionals would provide more value than outsourcing core functions to big tech.
7The Trust Factor Importance
National data guardian Dr. Nicola Byrne has advised ministers to prioritize the trust factor in their decision-making process. Over 44,000 individuals have filed legal objections regarding their health data being stored in the platform. This widespread public reluctance highlights a significant barrier to the successful adoption of the controversial data system.
8Future of NHS Procurement
The ongoing dispute underscores the tension between centralized tech procurement and local operational needs. While NHS England claims 137 trusts have reported benefits, the resistance from others suggests a fragmented implementation landscape. The government must now weigh these conflicting reports against public sentiment and the potential for more effective, home-grown digital alternatives.